Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Toshio Murase
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Anatomy
Procedures
Physiology
Sign-in to see full Profile
Network (preview)
27
Okubo, Minoru
14
Nakanishi, Koji
13
Kobayashi, Tetsuro
11
Horinishi, Asako
8
Ebara, Tetsu
6
Endo, Yoriko
4
Aoyama, Yoshiko
3
Amemiya-Kudo, Michiyo
3
Shin, Yoon
2
Podskarbi, Teodor
1
Shimano, Hitoshi
1
Osuga, Jun-ichi
1
Matsuzaka, Takashi
1
Odawara, Masato
1
Falorni, Alberto
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Toshio Murase (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Ebara Tetsu; Murase Toshio; Okubo Minoru
Pancreatitis caused by hypertriglyceridemia in a patient compound heterozygous for Leu334Phe and -514C-->T in the hepatic lipase gene.
Pancreas 2009;38(2):233-5.
-
2009: Endo Yoriko; Fateen Ekram; El Shabrawy Mortada; Aoyama Yoshiko; Ebara Tetsu; Murase Toshio; Podskarbi Teodor; Shin Yoon S; Okubo Minoru
Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(10):1233-8.
-
2008: Murase Toshio; Okubo Minoru; Amemiya-Kudo Michiyo; Ebara Tetsu; Mori Yasumichi
Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2008;57(6):791-5.
-
2007: Ebara Tetsu; Endo Yoriko; Yoshiike Shouichi; Tsuji Masatomi; Taguchi Susumu; Murase Toshio; Okubo Minoru
A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis.
Clinica chimica acta; international journal of clinical chemistry 2007;386(1-2):100-4.
-
2007: Okubo Minoru; Horinishi Asako; Saito Mieko; Ebara Tetsu; Endo Yoriko; Kaku Kohei; Murase Toshio; Eto Masaaki
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
Molecular genetics and metabolism 2007;92(3):229-33.
-
2007: Murase Toshio; Okubo Minoru; Amemiya-Kudo Michiyo; Hiraga Takaki; Oka Junko; Shimada Masako; Igarashi Tomio
Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
Metabolism: clinical and experimental 2007;56(9):1187-91.
-
2006: Endo Yoriko; Horinishi Asako; Vorgerd Matthias; Aoyama Yoshiko; Ebara Tetsu; Murase Toshio; Odawara Masato; Podskarbi Teodor; Shin Yoon S; Okubo Minoru
Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Journal of human genetics 2006;51(11):958-63.
-
2005: Amemiya-Kudo Michiyo; Oka Junko; Ide Tomohiro; Matsuzaka Takashi; Sone Hirohito; Yoshikawa Tomohiro; Yahagi Naoya; Ishibashi Shun; Osuga Jun-Ichi; Yamada Nobuhiro; Murase Toshio; Shimano Hitoshi
Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47.
The Journal of biological chemistry 2005;280(41):34577-89.
-
2005: Endo Yoriko; Fateen Ekram; Aoyama Yoshiko; Horinishi Asako; Ebara Tetsu; Murase Toshio; Shin Yoon S; Okubo Minoru
Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.
Journal of human genetics 2005;50(10):538-42.
-
2002: Murase Toshio
[Dyslipidemia in diabetes]
Nippon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 8():145-53.
-
2002: Tanaka Shoichiro; Kobayashi Tetsuro; Nakanishi Koji; Okubo Minoru; Odawara Masato; Murase Toshio; Hashimoto Masaji; Watanabe Goro; Matsushita Hiroshi; Inoko Hidetoshi; Takeuchi Kazuo
Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas.
Annals of the New York Academy of Sciences 2002;958():152-9.
-
2002: Okubo Minoru; Horinishi Asako; Kim Dong-Ho; Yamamoto Tokuo T; Murase Toshio
Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene.
Human mutation 2002;19(2):186.
-
2002: Horinishi Asako; Okubo Minoru; Tang Nelson L S; Hui Joannie; To Ka-Fai; Mabuchi Tomohito; Okada Toshihide; Mabuchi Hiroshi; Murase Toshio
Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Journal of human genetics 2002;47(2):55-9.
-
2001: Ebara T; Okubo M; Horinishi A; Adachi M; Murase T; Hirano T
No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61-->stop) in the lipoprotein lipase gene.
Atherosclerosis 2001;159(2):375-9.
-
2001: Murase T
[Hyperlipidemia in patients with ischemic heart disease]
Nippon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 3():722-7.
-
2001: Murase T
[Chylomicron]
Nippon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 2():50-3.
-
2000: Oki Y; Okubo M; Tanaka S; Nakanishi K; Kobayashi T; Murase T
Diabetes mellitus secondary to glycogen storage disease type III.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(11):810-2.
-
2000: Horinishi A; Murase T; Okubo M
Novel intronic polymorphisms (IVS6-73A/G and IVS21+124A/G) in the glycogen-debranching enzyme (AGL) gene.
Human mutation 2000;16(3):279.
-
2000: Okubo M; Horinishi A; Suzuki Y; Murase T; Hayasaka K
Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin.
American journal of medical genetics 2000;93(3):211-4.
-
2000: Okubo M; Horinishi A; Takeuchi M; Suzuki Y; Sakura N; Hasegawa Y; Igarashi T; Goto K; Tahara H; Uchimoto S; Omichi K; Kanno H; Hayasaka K; Murase T
Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.
Human genetics 2000;106(1):108-15.
-
1999: Okubo M; Kanda F; Horinishi A; Takahashi K; Okuda S; Chihara K; Murase T
Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.
Human mutation 1999;14(6):542-3.
-
1998: Okubo M; Horinishi A; Nakamura N; Aoyama Y; Hashimoto M; Endo Y; Murase T
A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb.
Human genetics 1998;102(1):1-5.
-
1998: Murase T
[High Lp (a) concentrations]
Ryoikibetsu shokogun shirizu 1998;(19 Pt 2):96-9.
-
1997: Okubo M; Murase T
[Management of lipid disorders in diabetes]
Nippon rinsho. Japanese journal of clinical medicine 1997;55 Suppl():776-80.
-
1997: Okubo M; Hasegawa Y; Aoyama Y; Murase T
A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient.
Atherosclerosis 1997;130(1-2):153-60.
-
1996: Hiraga T; Shimada M; Tsukada T; Murase T
Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1996;28(11):603-6.
-
1996: Kobayashi T; Oka Y; Katagiri H; Falorni A; Kasuga A; Takei I; Nakanishi K; Murase T; Kosaka K; Lernmark A
Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243.
Diabetologia 1996;39(10):1196-200.
-
1996: Okubo M; Aoyama Y; Murase T
A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III.
Biochemical and biophysical research communications 1996;224(2):493-9.
-
1996: Okubo M; Murase T
Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDDM.
Diabetes 1996;45 Suppl 3():S123-5.
-
1996: Kobayashi T; Nakanishi K; Murase T; Kosaka K
Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Diabetes 1996;45(5):622-6.
-
1996: Hiraga T; Shimada M; Okubo M; Nakanishi K; Kobayashi T; Murase T
Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions.
Atherosclerosis 1996;122(1):29-32.
-
1995: Hiraga T; Kobayashi T; Okubo M; Nakanishi K; Sugimoto T; Ohashi Y; Murase T
Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.
Diabetes care 1995;18(2):241-4.
-
1994: Murase T
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]
Nippon rinsho. Japanese journal of clinical medicine 1994;52(12):3221-7.
-
1994: Nakanishi K; Kobayashi T; Murase T; Kosaka K
Lack of association of the transporter associated with antigen processing with Japanese insulin-dependent diabetes mellitus.
Metabolism: clinical and experimental 1994;43(8):1013-7.
-
1994: Ohbayashi A; Hiraga T; Okubo M; Murase T; Matsushita H; Hara M
Characteristics of porcine coronary artery endothelial cells in culture: comparison with aortic endothelium.
Biochemical and biophysical research communications 1994;202(1):504-11.
-
1993: Hiraga T; Okubo M; Kobayashi T; Nakanishi K; Sugimoto T; Murase T
Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia.
Metabolism: clinical and experimental 1993;42(10):1327-30.
-
1993: Hiraga T; Shimokawa K; Murase T; Yokoyama M
Reduction of serum lipoprotein (a) by estrogen in men with prostatic cancer.
Endocrine journal 1993;40(5):507-13.
-
1993: Nakanishi K; Kobayashi T; Murase T; Nakatsuji T; Inoko H; Tsuji K; Kosaka K
Association of HLA-A24 with complete beta-cell destruction in IDDM.
Diabetes 1993;42(7):1086-93.
-
1993: Kobayashi T; Tamemoto K; Nakanishi K; Kato N; Okubo M; Kajio H; Sugimoto T; Murase T; Kosaka K
Immunogenetic and clinical characterization of slowly progressive IDDM.
Diabetes care 1993;16(5):780-8.
-
1990: Murase T
[Abnormalities of lipid metabolism in diabetes mellitus]
Nippon rinsho. Japanese journal of clinical medicine 1990;48 Suppl():652-8.
-
1990: Murase T
[Hyperlipoproteinemia: classification and current problems]
Nippon rinsho. Japanese journal of clinical medicine 1990;48(11):2519-25.
-
1990: Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
Metabolism: clinical and experimental 1990;39(9):925-30.
-
1990: Kobayashi T; Nakanishi K; Kajio H; Morinaga S; Sugimoto T; Murase T; Kosaka K
Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 1990;33(6):363-70.
-
1989: Kobayashi T; Nakanishi K; Sugimoto T; Itoh T; Murase T; Kosaka K; Tsuji K
Maleness as risk factor for slowly progressive IDDM.
Diabetes care 1989;12(1):7-11.
-
1988: Nakanishi K; Kobayashi T; Sugimoto T; Murase T; Itoh T; Kosaka K
Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetics.
Diabetes research (Edinburgh, Scotland) 1988;9(3):105-9.
Sign-in to see more